Ying Dong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ying Dong has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Jing Zhao
Department of Pathology, Health Science Center of Peking University, 38 Xueyuan Road, Haidian District, Beijing 100191, China
2 shared publications - Lin Nong
Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
2 shared publications - Ting Li
Department of Pathology, Peking University First Hospital, Beijing 100034, China
2 shared publications - Bo Zhang
Department of Pathology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xueyuan Road, Haidian District, Beijing 100191, China
1 shared publication - Haodong Xu
Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY
1 shared publication - Hongjuan Ti
Department of Pathology, Haidian Hospital of Beijing, Beijing 100080, China
1 shared publication
Latest Publications
- Open Access
- 17 January 2014
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 33 (1) , 7
The downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type
The mechanism for inactivation of positive regulatory domain containing I (PRDM1), a newly identified tumour suppressor gene in extranodal NK/T-cell lymphoma, nasal type (EN-NK/T-NT) has not been well defined. The aim of the present study was to investigate the expression of PRDM1 in EN-NK/T-NT and analyse its downregulation by miRNAs. PRDM1 and miRNA expression were evaluated in EN-NK/T-NT samples by immunohistochemical analysis, qRT-PCR, and in situ hybridisation. Luciferase assays were performed to verify the direct binding of miR-223 to the 3′-untranslated region of PRDM1 mRNA. In addition, the effect of miR-223 on PRDM1 expression was assessed in NK/T lymphoma cell lines by transfecting a miR-223 mimic or inhibitor to increase or decrease the effective expression of miR-223. Overall survival and failure-free survival in EN-NK/T-NT patients were analysed using Kaplan-Meier single-factor analysis and the log-rank test. Investigation of the downregulation of PRDM1 in EN-NK/T-NT cases revealed that PRDM1-positive staining might be a favourable predictor of overall survival and failure-free survival in EN-NK/T-NT patients. However, the negative staining of PRDM1 usually presented transcripts, suggesting a possible post-transcriptional regulation. miR-223 and its putative target gene, PRDM1, exhibited opposite patterns of expression in EN-NK/T-NT tissues and cell lines. Moreover, PRDM1 was identified as a direct target gene of miR-223 by luciferase assays. The ectopic expression of miR-223 led to the downregulation of the PRDM1 protein in the NK/T-cell lymphoma cell line, whereas a decrease in miR-223 restored the level of PRDM1 protein. Our findings reveal that the downregulation of the tumour suppressor PRDM1 in EN-NK/T-NT samples is mediated by miR-223 and that PRDM1-positive staining might have prognostic value for evaluating the clinical outcome of EN-NK/T-NT patients.
- 17 January 2014
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 33 (1) , 7
Open AccessThe downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type
The mechanism for inactivation of positive regulatory domain containing I (PRDM1), a newly identified tumour suppressor gene in extranodal NK/T-cell lymphoma, nasal type (EN-NK/T-NT) has not been well defined. The aim of the present study was to investigate the expression of PRDM1 in EN-NK/T-NT and analyse its downregulation by miRNAs. PRDM1 and miRNA expression were evaluated in EN-NK/T-NT samples by immunohistochemical analysis, qRT-PCR, and in situ hybridisation. Luciferase assays were performed to verify the direct binding of miR-223 to the 3′-untranslated region of PRDM1 mRNA. In addition, the effect of miR-223 on PRDM1 expression was assessed in NK/T lymphoma cell lines by transfecting a miR-223 mimic or inhibitor to increase or decrease the effective expression of miR-223. Overall survival and failure-free survival in EN-NK/T-NT patients were analysed using Kaplan-Meier single-factor analysis and the log-rank test. Investigation of the downregulation of PRDM1 in EN-NK/T-NT cases revealed that PRDM1-positive staining might be a favourable predictor of overall survival and failure-free survival in EN-NK/T-NT patients. However, the negative staining of PRDM1 usually presented transcripts, suggesting a possible post-transcriptional regulation. miR-223 and its putative target gene, PRDM1, exhibited opposite patterns of expression in EN-NK/T-NT tissues and cell lines. Moreover, PRDM1 was identified as a direct target gene of miR-223 by luciferase assays. The ectopic expression of miR-223 led to the downregulation of the PRDM1 protein in the NK/T-cell lymphoma cell line, whereas a decrease in miR-223 restored the level of PRDM1 protein. Our findings reveal that the downregulation of the tumour suppressor PRDM1 in EN-NK/T-NT samples is mediated by miR-223 and that PRDM1-positive staining might have prognostic value for evaluating the clinical outcome of EN-NK/T-NT patients.
- Open Access
- 18 February 2013
- Published by Springer Nature in Diagnostic Pathology
- Vol. 8 (1) , 27
Immunohistochemical detection of mutations in the epidermal growth factor receptor gene in lung adenocarcinomas using mutation-specific antibodies
The recent development of antibodies specific for the major hotspot mutations in the epidermal growth factor receptor (EGFR), L858R and E746_A750del, may provide an opportunity to use immunohistochemistry (IHC) as a screening test for EGFR gene mutations. This study was designed to optimize the IHC protocol and the criteria for interpretation of the results using DNA sequencing as the gold-standard. Tumor sections from fifty lung adenocarcinoma specimens from Chinese patients were immunostained using L858R and E746_A750del-specific antibodies using three different antigen retrieval solutions, and the results were evaluated using three different sets of criteria. The same specimens were used for DNA purification and analysis of EGFR gene mutations. In this study the optimal buffer for antigen retrieval was EDTA (pH 8.0), and the optimal scoring method was to call positive results when there was moderate to strong staining of membrane and/or cytoplasm in >10% of the tumor cells. Using the optimized protocol, L858R-specific IHC showed a sensitivity of 81% and a specificity of 97%, and E746_A750del-specific IHC showed a sensitivity of 59% and a specificity of 100%, both compared with direct DNA analysis. Additionally, the mutant proteins as assessed by IHC showed a more homogeneous than heterogeneous pattern of expression. Our data demonstrate that mutation-specific IHC, using optimized procedures, is a reliable prescreening test for detecting EGFR mutations in lung adenocarcinoma. The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/2059012601872392
- 18 February 2013
- Published by Springer Nature in Diagnostic Pathology
- Vol. 8 (1) , 27
Open AccessImmunohistochemical detection of mutations in the epidermal growth factor receptor gene in lung adenocarcinomas using mutation-specific antibodies
The recent development of antibodies specific for the major hotspot mutations in the epidermal growth factor receptor (EGFR), L858R and E746_A750del, may provide an opportunity to use immunohistochemistry (IHC) as a screening test for EGFR gene mutations. This study was designed to optimize the IHC protocol and the criteria for interpretation of the results using DNA sequencing as the gold-standard. Tumor sections from fifty lung adenocarcinoma specimens from Chinese patients were immunostained using L858R and E746_A750del-specific antibodies using three different antigen retrieval solutions, and the results were evaluated using three different sets of criteria. The same specimens were used for DNA purification and analysis of EGFR gene mutations. In this study the optimal buffer for antigen retrieval was EDTA (pH 8.0), and the optimal scoring method was to call positive results when there was moderate to strong staining of membrane and/or cytoplasm in >10% of the tumor cells. Using the optimized protocol, L858R-specific IHC showed a sensitivity of 81% and a specificity of 97%, and E746_A750del-specific IHC showed a sensitivity of 59% and a specificity of 100%, both compared with direct DNA analysis. Additionally, the mutant proteins as assessed by IHC showed a more homogeneous than heterogeneous pattern of expression. Our data demonstrate that mutation-specific IHC, using optimized procedures, is a reliable prescreening test for detecting EGFR mutations in lung adenocarcinoma. The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/2059012601872392
- 18 April 2011
- Vol. 43 (2) , 194-8
[Histopathological features of hydatidiform moles and placenta changes of nonmolar miscarriage in early stage of pregnancy].
To analyze the histology, immunohistochemistry expression of hydatidiform moles and placenta changes of related conception specimens in early pregnancy stage combined with genotyping detection by fluorescence in situ hybridization method for improving diagnosis of hydatidiform moles. A total of 32 cases of hydatidiform moles, problem cases, and hydropic abortuses were collected to study the morphology and the expression of p57KIP2, CD31. Two cases were analyzed the genotype with FISH method. Of the 32 cases, 24 were in early pregnancy stage and 8 in middle pregnancy stage. After validation study, all of the cases were subclassfied into four groups: complete hydatidiform mole (17 cases), partial hydatidiform mole (6 cases), abnormal villous morphology (4 cases) and hydropic abortus (5 cases). (1) The hydrops and central cistern formation were present but not marked in 25% (3/12) early complete hydatidiform moles. All of the cases of complete hydatidiform moles in early pregnancy stage consisted of trophoblastic hyperplasia but with mild nuclear pleomorphism in 75% cases. (2) P57KIP2 negative expression was significantly related with the morphology changes of early CHMs (Pearson correlation: 0.001 and 0.003, P0.05). (4) The genotyping analysis by fluorescence in situ hybridization method could provide support and might be generally performed in research settings. Immature blood vessels and excessive stromal karyorrhexis and apoptosis are characteristic features in early complete hydatidiform mole. p57KIP2 is a useful marker in diagnosis of complete hydatidiform mole in early pregnancy stage. The ancillary techniques will facilitate the diagnosis in cases of partial hydatidiform mole/abnormal villous morphology where histological features are usually inconclusive.
- 18 April 2011
- Vol. 43 (2) , 194-8
[Histopathological features of hydatidiform moles and placenta changes of nonmolar miscarriage in early stage of pregnancy].
To analyze the histology, immunohistochemistry expression of hydatidiform moles and placenta changes of related conception specimens in early pregnancy stage combined with genotyping detection by fluorescence in situ hybridization method for improving diagnosis of hydatidiform moles. A total of 32 cases of hydatidiform moles, problem cases, and hydropic abortuses were collected to study the morphology and the expression of p57KIP2, CD31. Two cases were analyzed the genotype with FISH method. Of the 32 cases, 24 were in early pregnancy stage and 8 in middle pregnancy stage. After validation study, all of the cases were subclassfied into four groups: complete hydatidiform mole (17 cases), partial hydatidiform mole (6 cases), abnormal villous morphology (4 cases) and hydropic abortus (5 cases). (1) The hydrops and central cistern formation were present but not marked in 25% (3/12) early complete hydatidiform moles. All of the cases of complete hydatidiform moles in early pregnancy stage consisted of trophoblastic hyperplasia but with mild nuclear pleomorphism in 75% cases. (2) P57KIP2 negative expression was significantly related with the morphology changes of early CHMs (Pearson correlation: 0.001 and 0.003, P0.05). (4) The genotyping analysis by fluorescence in situ hybridization method could provide support and might be generally performed in research settings. Immature blood vessels and excessive stromal karyorrhexis and apoptosis are characteristic features in early complete hydatidiform mole. p57KIP2 is a useful marker in diagnosis of complete hydatidiform mole in early pregnancy stage. The ancillary techniques will facilitate the diagnosis in cases of partial hydatidiform mole/abnormal villous morphology where histological features are usually inconclusive.